Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12252/3917
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2018-06-04T16:38:50Z
dc.date.available2026-02-19T08:53:40Z-
dc.date.issued2018-05-25
dc.identifier.urihttp://dspace.ncl.res.in:8080/xmlui/handle/20.500.12252/3917
dc.descriptionScientists from National Chemical Laboratory and the International Centre for Genetic Engineering and Biotechnology (ICGEB) have achieved a potential breakthrough in anti-malarial research. Three research groups, each led by NCL’s D Srinivasa Reddy and Dhanasekaran Shanmugam, and Amit Sharma of ICGEB, have identified fungal-metabolite molecules as a potential anti-malarial drug.en_US
dc.language.isoenen_US
dc.publisherTimes of India
dc.subjectAnti-Malarial Drugen_US
dc.subjectAdvanced Malaria Medicationen_US
dc.subjectCladosporin Moleculeen_US
dc.subjectAspergillus Flavusen_US
dc.titleScientists find potential leads to develop new anti-malarial drugsen_US
dc.title.alternativeMedication for Malariaen_US
dc.typeNewspaper Articleen_US
local.division.divisionOrganic Chemistry Divisionen_US
dc.description.universityen_US
Appears in Collections:Newspaper Clippings

Files in This Item:
File Description SizeFormat 
COMBATING MALARIA The Times Of India - Pune _ Friday, May 25, 2018 _ 5.pdfNEW DRUGS FOR MALARIA CO-DISCOVERED BY CSIR-NCL SCIENTISTS393.67 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.